POEMS syndrome

Revision as of 22:20, 13 January 2009 by C Michael Gibson (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

WikiDoc Resources for POEMS syndrome

Articles

Most recent articles on POEMS syndrome

Most cited articles on POEMS syndrome

Review articles on POEMS syndrome

Articles on POEMS syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on POEMS syndrome

Images of POEMS syndrome

Photos of POEMS syndrome

Podcasts & MP3s on POEMS syndrome

Videos on POEMS syndrome

Evidence Based Medicine

Cochrane Collaboration on POEMS syndrome

Bandolier on POEMS syndrome

TRIP on POEMS syndrome

Clinical Trials

Ongoing Trials on POEMS syndrome at Clinical Trials.gov

Trial results on POEMS syndrome

Clinical Trials on POEMS syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on POEMS syndrome

NICE Guidance on POEMS syndrome

NHS PRODIGY Guidance

FDA on POEMS syndrome

CDC on POEMS syndrome

Books

Books on POEMS syndrome

News

POEMS syndrome in the news

Be alerted to news on POEMS syndrome

News trends on POEMS syndrome

Commentary

Blogs on POEMS syndrome

Definitions

Definitions of POEMS syndrome

Patient Resources / Community

Patient resources on POEMS syndrome

Discussion groups on POEMS syndrome

Patient Handouts on POEMS syndrome

Directions to Hospitals Treating POEMS syndrome

Risk calculators and risk factors for POEMS syndrome

Healthcare Provider Resources

Symptoms of POEMS syndrome

Causes & Risk Factors for POEMS syndrome

Diagnostic studies for POEMS syndrome

Treatment of POEMS syndrome

Continuing Medical Education (CME)

CME Programs on POEMS syndrome

International

POEMS syndrome en Espanol

POEMS syndrome en Francais

Business

POEMS syndrome in the Marketplace

Patents on POEMS syndrome

Experimental / Informatics

List of terms related to POEMS syndrome

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.


Synonyms and Key Words: Crow-Fukase syndrome, Takatsuki disease, or PEP syndrome

Overview

POEMS syndrome is a rare medical syndrome named for its main clinically recognizable features: Polyneuropathy (peripheral nerve damage), Organomegaly (abnormal enlargement of organs), Endocrinopathy (damage to hormone-producing glands)/Edema, M-protein (an abnormal antibody) and Skin abnormalities (including hyperpigmentation and hypertrichosis).

Pathophysiology

While the main features of the disease have been described, the exact mechanism of the disease has remained elusive. The paraprotein alone is insufficient to explain the multi-organ features, and various cytokines produced by plasmacytoma cells have therefore been linked with the features of POEMS syndrome, specifically interleukin 1β, interleukin 6 and TNFα. There also seems to be a role of vascular endothelial growth factor, given the angiogenetic changes in many tissues.[1]

Diagnosis

It was originally described in part by various investigators, and received its present name in 1980 by Bardwick et al[2].

A 2003 study[1] followed a series of 99 patients and attempted to delineate criteria for the diagnosis of POEMS syndrome. According to their study, two major criteria and one minor criterion are required for the diagnosis:

In addition, their study showed a number of associations, the relevance of which to diagnosis was unclear: clubbing, weight loss, thrombocytosis, polycythemia and hyperhidrosis. Possible associations included pulmonary hypertension, restrictive lung disease, a thrombotic diathesis, arthralgia, cardiomyopathy (systolic dysfunction), fever, low vitamin B12 levels and diarrhea.

Treatment

Dispenzieri et al[1] list numerous treatments, the effect of many of which is almost anecdotal. Prednisolone and alkylating agents are the most commonly used.

References

  1. 1.0 1.1 1.2 Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496-506. PMID 12456500.
  2. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome: report on two cases and a review of the literature. Medicine (Baltimore) 1980;59:311-22. PMID 6248720.

External links

Template:SIB

Template:WikiDoc Sources